脳転移の高齢患者における外科切除の結果に影響する予後要因
Yu Chang1, Heng-Juei Hsu2, Chia-En Wong1,3
1Section of Neurosurgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
The Kaohsiung journal of medical sciences
|August 26, 2025
まとめ
脳転移 (BM) の高齢がん患者の場合,男性性,併発症,腫瘍の位置などの要因が生存に影響します. 整体的な治療と良い栄養状態 (PNI) は,個別化された手術決定を導く結果を改善します.
科学分野:
- 腫瘍学
- 神経外科
- 高齢者医療
背景:
- 脳転移 (BM) は高齢のがん患者で増加しています.
- 併発性疾患によるBMの高齢患者の治療決定は複雑です.
- 予後要因を特定することは 切除手術の決定を最適化するために重要です
研究 の 目的:
- BMを患っている高齢者の外科切除の予後要因を特定する.
- この患者集団の情報に基づいた治療決定を支援する.
主な方法:
- 手術を受けたBMと新たに診断された124人の高齢患者 (≥65歳) の遡及研究.
- 生存分析とコックス回帰分析は,生存の独立した予測要因を特定するために行われました.
- 分析された要因には,性別,頭蓋の外転移 (ECM),骨髄の位置,カルノフスキー性能状態 (KPS),改変した脆弱性指数 (mFI-5),全身治療,全身免疫炎症指数 (SII),および予後栄養指数 (PNI) が含まれていた.
主要な成果:
- 低生存率は男性,ECM,雄弁な場所でのBM,KPSの悪化,およびmFI-5 ≥2と関連していました.
- 診断後の全身治療により,全生存率が有意に改善されました (HR: 0. 45).
- 高いSII (HR: 1.99) は生存率の低下と相関し,高いPNI (HR: 0.56) は生存率の向上を示した.
結論:
- BMの位置,ECM,併発症,全身治療の適性などを考慮して,高齢のBM患者に個別化されたアプローチが不可欠です.
- 術前の栄養状態と炎症状態 (PNI,SII) とパフォーマンス状態 (KPS) は重要な予後指標である.
- 術前と術後のこれらの要因のモニタリングは,治療戦略を導き,患者の治療結果を改善するのに役立ちます.
関連する概念動画
Factors Affecting Renal Clearance: Renal Impairment
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...


